WallStSmart

Hubbell Inc (HUBB)vsWest Pharmaceutical Services Inc (WST)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Hubbell Inc generates 90% more annual revenue ($5.84B vs $3.07B). WST leads profitability with a 16.1% profit margin vs 15.2%. HUBB appears more attractively valued with a PEG of 2.31. HUBB earns a higher WallStSmart Score of 61/100 (C+).

HUBB

Buy

61

out of 100

Grade: C+

Growth: 6.0Profit: 8.0Value: 8.0Quality: 5.5
Piotroski: 4/9

WST

Buy

55

out of 100

Grade: C-

Growth: 4.7Profit: 8.0Value: 4.7Quality: 7.3
Piotroski: 5/9Altman Z: 4.91
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

HUBBOvervalued (-8.1%)

Margin of Safety

-8.1%

Fair Value

$477.39

Current Price

$480.97

$3.58 premium

UndervaluedFair: $477.39Overvalued
WSTSignificantly Overvalued (-256.8%)

Margin of Safety

-256.8%

Fair Value

$68.99

Current Price

$243.35

$174.36 premium

UndervaluedFair: $68.99Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HUBB1 strengths · Avg: 9.0/10
Return on EquityProfitability
24.5%9/10

Every $100 of equity generates 25 in profit

WST2 strengths · Avg: 9.0/10
Altman Z-ScoreHealth
4.9110/10

Safe zone — low bankruptcy risk

Operating MarginProfitability
21.6%8/10

Strong operational efficiency at 21.6%

Areas to Watch

HUBB2 concerns · Avg: 4.0/10
PEG RatioValuation
2.314/10

Expensive relative to growth rate

P/E RatioValuation
30.6x4/10

Premium valuation, high expectations priced in

WST3 concerns · Avg: 3.3/10
P/E RatioValuation
36.1x4/10

Premium valuation, high expectations priced in

EPS GrowthGrowth
2.1%4/10

2.1% earnings growth

PEG RatioValuation
2.892/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : HUBB

The strongest argument for HUBB centers on Return on Equity. Profitability is solid with margins at 15.2% and operating margin at 19.1%. Revenue growth of 11.9% demonstrates continued momentum.

Bull Case : WST

The strongest argument for WST centers on Altman Z-Score, Operating Margin. Profitability is solid with margins at 16.1% and operating margin at 21.6%.

Bear Case : HUBB

The primary concerns for HUBB are PEG Ratio, P/E Ratio.

Bear Case : WST

The primary concerns for WST are P/E Ratio, EPS Growth, PEG Ratio.

Key Dynamics to Monitor

WST carries more volatility with a beta of 1.18 — expect wider price swings.

HUBB is growing revenue faster at 11.9% — sustainability is the question.

HUBB generates stronger free cash flow (389M), providing more financial flexibility.

Monitor ELECTRICAL EQUIPMENT & PARTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

HUBB scores higher overall (61/100 vs 55/100), backed by strong 15.2% margins and 11.9% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Hubbell Inc

INDUSTRIALS · ELECTRICAL EQUIPMENT & PARTS · USA

Hubbell Incorporated designs, manufactures, and sells electrical and electronic products in the United States and internationally. The company is headquartered in Shelton, Connecticut.

West Pharmaceutical Services Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. The company is headquartered in Exton, Pennsylvania.

Want to dig deeper into these stocks?